XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 418 $ 345
Funds deposited by counterparties 36 32
Restricted cash 8 8
Accounts receivable, net 1,015 1,025
Inventory 388 383
Derivative instruments 791 860
Cash collateral paid in support of energy risk management activities 136 190
Prepayments and other current assets 284 245
Total current assets 3,076 3,088
Property, plant and equipment, net 2,533 2,593
Other Assets    
Equity investments in affiliates 372 388
Operating lease right-of-use assets, net 429 464
Goodwill 579 579
Intangible assets, net 733 789
Nuclear decommissioning trust fund 794 794
Derivative instruments 439 310
Deferred income taxes 3,170 3,286
Other non-current assets 212 240
Total other assets 6,728 6,850
Total Assets 12,337 12,531
Current Liabilities    
Current portion of long-term debt 7 88
Current portion of operating lease liabilities 69 73
Accounts payable 736 722
Derivative instruments 728 781
Cash collateral received in support of energy risk management activities 36 32
Accrued expenses and other current liabilities 581 663
Total current liabilities 2,157 2,359
Other Liabilities    
Long-term debt 5,810 5,803
Non-current operating lease liabilities 458 483
Nuclear decommissioning reserve 307 298
Nuclear decommissioning trust liability 478 487
Derivative instruments 299 322
Deferred income taxes 17 17
Other non-current liabilities 1,061 1,084
Total other liabilities 8,430 8,494
Total Liabilities 10,587 10,853
Redeemable noncontrolling interest in subsidiaries 0 20
Commitments and Contingencies
Stockholders' Equity    
Common stock; $0.01 par value; 500,000,000 shares authorized; 423,031,777 and 421,890,790 shares issued and 244,137,848 and 248,996,189 shares outstanding at June 30, 2020 and December 31, 2019, respectively 4 4
Additional paid-in-capital 8,505 8,501
Accumulated deficit (1,331) (1,616)
Treasury stock, at cost - 178,893,929 and 172,894,601 shares at June 30, 2020 and December 31, 2019, respectively (5,234) (5,039)
Accumulated other comprehensive loss (194) (192)
Total Stockholders' Equity 1,750 1,658
Total Liabilities and Stockholders' Equity $ 12,337 $ 12,531
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, par or value (in usd per share) $ 0.01 $ 0.01